Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

4f9d6ab3d898ec30bcf30036719.-oyRKllqTcTqJEpNGfvejbngyBBaVOHYMp3nnBMGS7I.mP-jWBo_Ov27bSkHerqf3-immkcgIamIVaut9CFuJvOJ1NhwLV9gvqx7IQ~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +20.36%
+60.74%
-9.7%
+77.11%
- - +35.69%
+39.05%
Average +37.21%
Weighted average by Cap. +40.52%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.97USD
Average target price
118.00USD
Spread / Average Target
+16.87%
High Price Target
120.00USD
Spread / Highest target
+18.85%
Low Price Target
116.00USD
Spread / Lowest Target
+14.89%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.97USD
Average target price
118.00USD
Spread / Average Target
+16.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION